Trial · NCT07885566
RWS of PDT for CIN 2
NCT07885566, Not yet recruiting, Tongji Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. RWS of PDT for CIN 2. Trials, record NCT07885566. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885566
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- RWS of PDT for CIN 2
- NCT number
- NCT07885566
- Status
- Not yet recruiting
- Enrollment
- 1,000 participants, estimated
- Lead sponsor
- Tongji Hospital
- Conditions
- Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
- Interventions
- Hexaminolevulinate (HAL)
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pathological Remission Rate at 6 Months | 6 months after the initial PDT treatment | Pathological remission is defined as a cervical biopsy showing normal tissue or CIN1/low-grade squamous intraepithelial lesion (LSIL). The pathological remission rate is the proportion of participants meeting this definition at 6 months after the initial PDT treatment. |
| Secondary | HPV Clearance Rate at 3 Months | 3 months after the initial PDT treatment | The proportion of participants with clearance of HPV infection at 3 months after the initial PDT treatment, based on HPV testing. |
| Secondary | HPV Clearance Rate at 6 Months | 6 months after the initial PDT treatment | The proportion of participants with clearance of HPV infection at 6 months after the initial PDT treatment, based on HPV testing. |
| Secondary | Incidence and Severity of Treatment-Related Adverse Events | From the first PDT treatment through the 12-month follow-up period | The incidence and severity of adverse events considered related to PDT will be recorded. Adverse event severity will be assessed according to the Common Terminology Criteria for Adverse Events (CTCAE), version 5.0. |
| Secondary | Pathological Remission Rate at 12 Months | 12 months after the initial PDT treatment | The proportion of participants with pathological remission at 12 months after the initial PDT treatment. Pathological remission is defined as a cervical biopsy showing normal tissue or CIN1/LSIL. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885566
GET https://conductscience.org/api/trials/v1/NCT07885566/registered